Friday, December 13, 2019

Revolutionary Erectile Dysfunction Treatment, GAINSWave®, Now Offered by Havkin Urology in Florida

Havkin Urology is implementing a non-invasive and drug free solution for Erectile Dysfunction (ED) called GAINSWave, which boasts a 75% success rate. GAINSWave is a premium brand of shockwave therapy designed to remove micro-plaque and stimulate...

Denteractive Launches 24/7 Live Online Dental Advice Service

Denteractive, an online teledentistry platform, launched a service that provides instant live professional responses to dental consumers. This service is available online 24/7, at all times of day and night. This allows people to receive advice...

Pharmaceutical Industry Study Focuses on Using Medical Affairs to Improve Payer Interactions

In the wake of the rising influence of public and private payers, pharmaceutical companies are seeking more effective ways to work with payer organizations. In particular, pharma is turning to the medical affairs function to...

Thermo Fisher Scientific Opens New Bioprocess Design Center in Shanghai

Facility enables customer collaboration to optimize bioprocessing solutions Thermo Fisher Scientific, the world leader in serving science, today opened its first Bioprocess Design Center in Shanghai, China. The new center is part of a strategy to...

EDGC to Launch Liquid Biopsy Screening Service, Technology for Early Detection of Cancers, This...

Liquid biopsy drawing attention for preventing the recurrence of cancer and allowing for early detection of cancers EDGC develops the most advanced lipuid biopsy technology EONE-DIAGNOMICS Genome Center (EDGC), a global company in genetic analysis, has announced the...

AIVITA Biomedical Attains Japanese PMDA Milestone for ROOT OF CANCER Technology

Manufacturing, quality and safety data deemed acceptable by Japanese regulatory agency in AIVITA's effort to commercialize ROOT OF CANCER technology AIVITA Biomedical announced today the successful completion of the manufacturing quality consultation and clinical safety...

Aralez Pharmaceuticals To Enter Into Purchase Agreements To Sell Substantially All Assets

Company to Continue Operating Business and Serving Customers As Usual Aralez Pharmaceuticals Inc. announced today that it intends to enter into purchase agreements with two separate stalking-horse purchasers to sell its main operating businesses:  an...

MiMedx Receives Regulatory Approval to Commercialize Product Portfolio in Australia

Partners with Leading Australian Healthcare Products and Biological Supplier MiMedx Group, Inc., a leading developer and marketer of regenerative and therapeutic biologics, today announced that it received regulatory approval from the Therapeutics Goods Administration (TGA)...

Autologous Stem Cell Therapy May Hold Key to Regeneration

USRM Chief Science Officer's Live Webinar Adds Voice to Debate U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced the...

Lilly Announces Agreement To Acquire ARMO BioSciences

.6 billion transaction will bolster Lilly's clinical portfolio with ARMO's lead immuno-oncology asset, pegilodecakin, which is being studied in multiple tumor types Eli Lilly and Company and ARMO BioSciences, Inc. today announced a definitive agreement...

Connect with us

4,472FansLike
1,007FollowersFollow
3,526FollowersFollow

Popular Posts